Drugs & TargetsFree FDA grants Breakthrough Therapy Designation for JNJ-6372 in NSCLC indication March 13, 2020Vol.46 No.11
Drugs & TargetsFree Thermo Fisher Scientific collaborates with Janssen to co-develop companion diagnostic for cancer March 13, 2020Vol.46 No.11
Drugs & TargetsFree European Commission approves Venclyxto in CLL indication March 13, 2020Vol.46 No.11
Drugs & Targets FDA approves Sarclisa in patients with previously treated MM March 06, 2020Vol.46 No.10
Drugs & Targets FDA grants RMAT designation for CD30 CAR-T cell therapy in Hodgkin lymphoma indication March 06, 2020Vol.46 No.10
Drugs & Targets FDA grants tipifarnib Fast Track designation in T-cell lymphomas March 06, 2020Vol.46 No.10
Drugs & Targets FDA approves neratinib for metastatic HER2-positive breast cancer February 28, 2020Vol.46 No.09
Drugs & Targets FDA accepts sNDA for Zejula in ovarian cancer indication February 28, 2020Vol.46 No.09
Drugs & Targets FDA grants RMAT designation to CD30 CAR-T Cell Therapy in hodgkin lymphoma indication February 28, 2020Vol.46 No.09
